Previous studies of the obese rat model of T2D have shown that the upregulated protein levels of AMPD3 could impair cardiac energy by targeting ATP depletion and systolic dysfunction (Tatekoshi et al., 2018; Igaki et al., 2021; Ogawa et al., 2023). Here, AMPD3 is linked to type 2 diabetes mellitus.